Home / MYT1 Knockout Cell Lines

MYT1 Knockout Cell Lines

Gene: MYT1

Official Full Name: myelin transcription factor 1provided by HGNC

Gene Summary: The protein encoded by this gene is a member of a family of neural specific, zinc finger-containing DNA-binding proteins. The protein binds to the promoter regions of proteolipid proteins of the central nervous system and plays a role in the developing nervous system. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO04992 MYT1 Knockout cell line (HCT 116) Human MYT1 1:2~1:4 Negative Online Inquiry
KO04993 MYT1 Knockout cell line (A549) Human MYT1 1:3~1:4 Negative Online Inquiry

Background

MYT1 Gene Knockout Cell Lines are specifically engineered cells that feature a targeted disruption of the MYT1 gene, which encodes a transcription factor known to play a pivotal role in neuronal differentiation and development. These knockout cell lines enable a deeper understanding of the biological pathways regulated by MYT1, providing researchers with a vital tool to study neurogenesis and related cellular processes.

The key mechanism by which these cell lines operate involves the homology-directed repair (HDR) pathway, allowing for precise gene editing. By employing CRISPR-Cas9 technology, the MYT1 gene can be effectively knocked out, resulting in cells devoid of MYT1 activity. This genetic modification permits scientists to observe the subsequent phenotypic and functional changes in cellular behavior, making it a critical component for numerous research applications.

In terms of scientific importance, MYT1 Gene Knockout Cell Lines are invaluable in neurobiological research. Their use can extend to drug discovery, where understanding the role of MYT1 can elucidate potential therapeutic targets for neurodegenerative diseases. Furthermore, these cell lines facilitate the exploration of gene function in developmental biology and the molecular mechanisms underpinning various neurological disorders in both research and clinical settings.

What sets our MYT1 Gene Knockout Cell Lines apart from alternatives is their high specificity and the reliability of their genetic modifications. The precision of our CRISPR-Cas9 methodology minimizes off-target effects, ensuring that researchers have a consistent and trustworthy platform for their studies. Additionally, we provide comprehensive user support, including detailed characterization reports and experimental guidance, further enhancing the product's value.

For researchers and clinicians aiming to explore the complexities of neurobiology, the MYT1 Gene Knockout Cell Lines represent an essential asset that can accelerate discoveries and foster innovation. Our company, with a proven track record in advanced genetic technologies and a commitment to high-quality biological products, stands ready to support your cutting-edge research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.